217 related articles for article (PubMed ID: 26851186)
1. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
Vieyra-Garcia PA; Wei T; Naym DG; Fredholm S; Fink-Puches R; Cerroni L; Odum N; O'Malley JT; Gniadecki R; Wolf P
Clin Cancer Res; 2016 Jul; 22(13):3328-39. PubMed ID: 26851186
[TBL] [Abstract][Full Text] [Related]
2. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
3. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).
Willerslev-Olsen A; Litvinov IV; Fredholm SM; Petersen DL; Sibbesen NA; Gniadecki R; Zhang Q; Bonefeld CM; Wasik MA; Geisler C; Zhou Y; Woetmann A; Sasseville D; Krejsgaard T; Odum N
Cell Cycle; 2014; 13(8):1306-12. PubMed ID: 24621498
[TBL] [Abstract][Full Text] [Related]
4. Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction.
Tamiya T; Ichiyama K; Kotani H; Fukaya T; Sekiya T; Shichita T; Honma K; Yui K; Matsuyama T; Nakao T; Fukuyama S; Inoue H; Nomura M; Yoshimura A
J Immunol; 2013 Sep; 191(5):2360-71. PubMed ID: 23913959
[TBL] [Abstract][Full Text] [Related]
5. STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.
Fredholm S; Gjerdrum LM; Willerslev-Olsen A; Petersen DL; Nielsen IØ; Kauczok CS; Wobser M; Ralfkiaer U; Bonefeld CM; Wasik MA; Krejsgaard T; Geisler C; Ralfkiaer E; Gniadecki R; Woetmann A; Odum N
Anticancer Res; 2014 Oct; 34(10):5277-86. PubMed ID: 25275020
[TBL] [Abstract][Full Text] [Related]
6. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells.
Staudt V; Bothur E; Klein M; Lingnau K; Reuter S; Grebe N; Gerlitzki B; Hoffmann M; Ulges A; Taube C; Dehzad N; Becker M; Stassen M; Steinborn A; Lohoff M; Schild H; Schmitt E; Bopp T
Immunity; 2010 Aug; 33(2):192-202. PubMed ID: 20674401
[TBL] [Abstract][Full Text] [Related]
7. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract][Full Text] [Related]
8. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
9. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
11. Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.
Ni X; Jorgensen JL; Goswami M; Challagundla P; Decker WK; Kim YH; Duvic MA
Clin Cancer Res; 2015 Jan; 21(2):274-85. PubMed ID: 25376389
[TBL] [Abstract][Full Text] [Related]
12. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4.
Campos Carrascosa L; Klein M; Kitagawa Y; Lückel C; Marini F; König A; Guralnik A; Raifer H; Hagner-Benes S; Rädler D; Böck A; Kang C; Lohoff M; Garn H; Schaub B; Berberich-Siebelt F; Sakaguchi S; Bopp T; Huber M
Nat Commun; 2017 May; 8():15366. PubMed ID: 28497800
[TBL] [Abstract][Full Text] [Related]
14. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.
Sommer VH; Clemmensen OJ; Nielsen O; Wasik M; Lovato P; Brender C; Eriksen KW; Woetmann A; Kaestel CG; Nissen MH; Ropke C; Skov S; Ødum N
Leukemia; 2004 Jul; 18(7):1288-95. PubMed ID: 15141228
[TBL] [Abstract][Full Text] [Related]
15. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
[TBL] [Abstract][Full Text] [Related]
16. CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.
Herrmann A; Priceman SJ; Swiderski P; Kujawski M; Xin H; Cherryholmes GA; Zhang W; Zhang C; Lahtz C; Kowolik C; Forman SJ; Kortylewski M; Yu H
J Clin Invest; 2014 Jul; 124(7):2977-87. PubMed ID: 24892807
[TBL] [Abstract][Full Text] [Related]
17. The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients.
Kumar S; Dhamija B; Marathe S; Ghosh S; Dwivedi A; Karulkar A; Sharma N; Sengar M; Sridhar E; Bonda A; Thorat J; Tembhare P; Shet T; Gujral S; Bagal B; Laskar S; Jain H; Purwar R
Mol Cancer Res; 2020 Apr; 18(4):657-668. PubMed ID: 31996468
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells.
Rindler K; Bauer WM; Jonak C; Wielscher M; Shaw LE; Rojahn TB; Thaler FM; Porkert S; Simonitsch-Klupp I; Weninger W; Mayerhoefer ME; Farlik M; Brunner PM
Front Immunol; 2021; 12():666935. PubMed ID: 33968070
[TBL] [Abstract][Full Text] [Related]
19. PUVA-induced pityriasis lichenoides chronica-like papular lesions in patients with mycosis fungoides: a clinical, histopathological and immunohistochemical study.
Youssef R; Abdel-Halim MRE; Abdel Halim DM; Fawzy MM; Hussein MF; Elmasry MF; Sayed SS; Abo Eid NM
Arch Dermatol Res; 2019 Nov; 311(9):673-678. PubMed ID: 31300833
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
